Global Growth Driving Factors:

The major factors driving the growth of fill finish manufacturing market include rising technological advancements in fill-finish manufacturing processes, the growth of the biopharmaceutical industry, and the rising adoption of prefilled syringes for parenteral dosage forms. The rise in outsourcing of fill-finish operations and the untapped potential in emerging markets offer a significant scope of growth in the fill-finish manufacturing industry.

Projected Surge in Revenue:

The global fill finish manufacturing market size is projected to grow from USD 7.5 billion in 2020 to USD 12.1 billion by 2025, at a CAGR of 10.0% during the forecast period.

Geographical Growth Dynamics:

In terms of geographical coverage, the fill finish manufacturing market is divided into five major regions—Europe, North America, Asia Pacific, LATAM, and the MEA. In 2019, Europe was the largest contributor to the global fill finish manufacturing market, followed by North America. This regional growth can be attributed primarily to the growing focus on the development of biosimilar due to the patent expiry of key biologics products.

The Asia Pacific region is estimated to grow at the highest CAGR in the fill-finish manufacturing industry during the forecast period, mainly due to the presence of a large number of CMOs in China & India, increasing government support, low production and labor costs, and less-stringent regulations in comparison to other developed nations.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=6249609

End Users:

Based on end-users, the fill finish manufacturing market is segmented into contract manufacturing organizations, biopharmaceutical & pharmaceutical companies, and others (including research & development laboratories and academic research institutions). The contract manufacturing organizations segment dominated the fill-finish manufacturing industry in 2019. This can primarily be attributed to the rising demand for outsourcing of fill-finish manufacturing processes from small-sized biopharmaceutical companies and the growing number of new entrants in the biologics manufacturing market.

Key Players:

The major companies in the fill finish manufacturing market include Becton, Dickson and Company (US), Syntegon Technology GmbH (Germany), I.M.A. (Industria Macchine Automatiche) S.p.A. (Italy), Stevanato Group (Italy), West Pharmaceutical Services, Inc. (US), OPTIMA Packaging Group GmbH (Germany), Bausch+Strobel (Germany), Groninger & Co. GmbH (Germany), and Gerresheimer AG (Germany).

Syntegon Technology GmbH (Germany) is one of the leading players in the global fill finish manufacturing market. In 2019, the company’s revenue was approximately USD 1.4 billion. The company offers an extensive product portfolio in the market through its machinery systems segment, which includes a wide range of automated standalone machines, integrated systems, and barrier systems such as isolator systems and RABS. Over the years, isolators and RABS have witnessed increasing adoption by many pharmaceutical and biopharmaceutical companies to maintain high-quality product standards. The company also adopts organic strategies such as product launches to maintain its position in this market.

Recent developments:

# In 2017, Syntegon Technology GmbH (Germany) launched a technologically advanced filling and closing machine, ALF 5000.
# In 2017, IMA S.P.A. (Industria Macchine Automatiche) launched an integrated fill-finish machine, INJECTA.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=6249609